Home
>>
Products
>>
Antibodies
>>
Recombinant Antibodies
>
Anti-Human CD192 Recombinant Antibody

Anti-Human CD192 Recombinant Antibody

Product Number

YR1384

Alias

科研级 Plozalizumab ( 洛扎利珠单抗 ), Anti-CD192 Recombinant Antibody, Research Grade Plozalizumab

Specifications
  • 1mg
  • 5mg
Product Description
Alias科研级 Plozalizumab ( 洛扎利珠单抗 ), Anti-CD192 Recombinant Antibody, Research Grade Plozalizumab
Catalog NumberYR1384
Molecular NamePlozalizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundPlozalizumab (INN, hu1D9) is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency. This drug was developed by Takeda Pharmaceuticals International Co.
CAS Number1610761-46-0
ApplicationELISA, IHC, IF, IP, FCM, Inhib
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCD192[Homo sapiens]

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now